Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
1 clinical trials · Condition
◉ Watch Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
| Record | Firm | Date |
|---|---|---|
| Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort (NCT04979780) | Bayer | 2021-07-20 |
Track Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients automatically
Every clearance here is in the API, with alerts when new ones post.